We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$6.99B
AUM Growth
+$1.23B
Cap. Flow
-$140M
Cap. Flow %
-2%
Top 10 Hldgs %
22.95%
Holding
1,634
New
85
Increased
643
Reduced
463
Closed
238

Top Buys

Rank Stock Value
1
DBRG icon
DigitalBridge
DBRG
+$21.6M
2
GDS icon
GDS Holdings
GDS
+$16.6M
3
DELL icon
Dell
DELL
+$12.3M
4
PARA
Paramount Global Class B
PARA
+$12M
5
LUMN icon
Lumen
LUMN
+$11M

Sector Composition

Rank Sector Weight
1 Real Estate 16.24%
2 Technology 13.67%
3 Consumer Discretionary 10.4%
4 Healthcare 8.54%
5 Communication Services 6.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRTA icon
1351
Prothena Corp
PRTA
$458M
-952
Closed -$24K
PTBD icon
1352
Pacer Trendpilot US Bond ETF
PTBD
$87M
-286,037
Closed -$7.8M
PTCT icon
1353
PTC Therapeutics
PTCT
$6.37B
-1,327
Closed -$63K
PTGX icon
1354
Protagonist Therapeutics
PTGX
$8.75B
-1,780
Closed -$46K
PTIN icon
1355
Pacer Trendpilot International ETF
PTIN
$180M
-294,940
Closed -$8.14M
PTLC icon
1356
Pacer Trendpilot US Large Cap ETF
PTLC
$3.24B
-240,707
Closed -$8.36M
PTMC icon
1357
Pacer Trendpilot US Mid Cap ETF
PTMC
$396M
-240,680
Closed -$8.38M
PTNQ icon
1358
Pacer Trendpilot 100 ETF
PTNQ
$1.2B
-150,528
Closed -$7.89M
QNCX icon
1359
Quince Therapeutics
QNCX
$17.5M
-6
Closed -$45K
QURE icon
1360
uniQure
QURE
$2.68B
-2,296
Closed -$77K
RARE icon
1361
Ultragenyx Pharmaceutical
RARE
$2.65B
-609
Closed -$69K
RCEL icon
1362
Avita Medical
RCEL
$142M
-697
Closed -$14K
RCKT icon
1363
Rocket Pharmaceuticals
RCKT
$348M
-1,447
Closed -$64K
RCUS icon
1364
Arcus Biosciences
RCUS
$3.57B
-2,145
Closed -$60K
RDNT icon
1365
RadNet
RDNT
$4.84B
-85,928
Closed -$1.87M
REPL icon
1366
Replimune Group
REPL
$814M
-2,288
Closed -$70K
RGNX icon
1367
Regenxbio
RGNX
$623M
-1,914
Closed -$65K
RGR icon
1368
Sturm, Ruger & Co
RGR
$610M
-14,377
Closed -$950K
RIGL icon
1369
Rigel Pharmaceuticals
RIGL
$680M
-1,464
Closed -$50K
RLAY icon
1370
Relay Therapeutics
RLAY
$4.02B
-1,981
Closed -$68K
RNAM
1371
DELISTED
Avidity Biosciences
RNAM
-1,417
Closed -$31K
RVMD icon
1372
Revolution Medicines
RVMD
$40.2B
-1,630
Closed -$75K
RYTM icon
1373
Rhythm Pharmaceuticals
RYTM
$7B
-2,845
Closed -$61K
SAGE
1374
DELISTED
Sage Therapeutics
SAGE
-991
Closed -$74K
SAH icon
1375
Sonic Automotive
SAH
$3.15B
-88,258
Closed -$4.38M

Similar funds

Pacer Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Pacer Advisors held 1,634 positions worth $6.99B, up 21% from $5.75B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Pacer Advisors's Q2 2021 filing shows 85 new, 643 increased, 463 reduced and 238 closed positions. Its largest new stake was DigitalBridge: 754,679 shares worth $23.8M. The largest sale was Crown Castle, an estimated $11.5M.

By sector, the portfolio is most concentrated in Real Estate at 16% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Pacer Advisors's largest Q2 2021 buy was DigitalBridge: 754,679 shares worth $23.8M.
  • Pacer Advisors added most to GDS Holdings in Q2 2021, an estimated $16.6M increase.
  • Pacer Advisors's biggest Q2 2021 reduction was Crown Castle, cutting an estimated $11.5M.
  • Pacer Advisors fully exited Pacer Trendpilot US Mid Cap ETF in Q2 2021, selling an estimated $8.38M.
  • Pacer Advisors's ten largest holdings make up 23% of its $6.99B portfolio in Q2 2021.
  • Pacer Advisors opened 85 new positions and closed 238 in Q2 2021.
  • Pacer Advisors's portfolio value rose 21% quarter-over-quarter to $6.99B.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.